Cardiopulmonary exercise test and sudden cardiac death risk in hypertrophic cardiomyopathy

Damiano Magrì1, Giuseppe Limongelli2, Federica Re3

  • 1Department of Clinical and Molecular Medicine, University of Rome "La Sapienza", Rome, Italy.

Insights

The ventilation/carbon dioxide relation (VE/VCO2) slope during exercise testing can improve sudden cardiac death (SCD) risk stratification in hypertrophic cardiomyopathy (HCM) patients. This cardiopulmonary exercise test metric offers valuable insights beyond current risk scores.

Area of Science:

  • Cardiology
  • Exercise Physiology
  • Sudden Cardiac Death Research

Background:

  • Hypertrophic cardiomyopathy (HCM) presents complex risks for sudden cardiac death (SCD).
  • Factors influencing SCD risk in HCM often overlap with exercise limitation pathophysiology.
  • Current SCD risk stratification strategies in HCM require refinement.

Purpose of the Study:

  • To evaluate the utility of cardiopulmonary exercise testing (CPET) in enhancing SCD risk stratification for HCM patients.
  • To determine if the ventilation/carbon dioxide relation (VE/VCO2) slope improves upon existing risk assessment models.

Main Methods:

  • A prospective, multicentre study followed 623 consecutive HCM outpatients from 2007 to 2015.
  • The composite endpoint included SCD, aborted SCD, and appropriate implantable cardioverter-defibrillator (ICD) interventions.
  • Multivariate analysis assessed the VE/VCO2 slope's association with the study endpoint, comparing it with established guideline-derived scores.

Main Results:

  • During a median follow-up of 3.7 years, 25 patients reached the composite endpoint.
  • The VE/VCO2 slope independently predicted the study endpoint, showing high concordance indices (0.748-0.750) with guideline scores.
  • A VE/VCO2 slope cut-off of 31 demonstrated good accuracy (AUC 0.72) for predicting SCD events.

Conclusions:

  • The VE/VCO2 slope shows potential to augment SCD risk stratification in HCM, especially for low-intermediate risk patients.
  • This CPET-derived metric may offer incremental value beyond current risk stratification guidelines.
  • Further validation in larger, independent cohorts is warranted to confirm these findings.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
671
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
621
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
743
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
5.0K
Exercise Stress Test01:26

Exercise Stress Test

Introduction
Exercise stress testing, commonly known as a treadmill test, is a noninvasive procedure used to evaluate cardiovascular function and diagnose heart conditions.
Definition
An exercise stress test measures the heart's response to exertion using a treadmill or stationary bicycle. Chest electrodes record the heart's electrical activity through an ECG, and blood pressure is monitored regularly.
Purposes
1.8K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
796